Editas Medicine Inc (EDIT) Cena delnic in novice – Google Finance

Finance

Domača stranEDIT • NASDAQ

Editas Medicine Inc

2,02 $

Po zaprtju:

2,02 $

(0,079 %)+0,0016

Konec trgovanja: 20. jan., 18:24:38 GMT -5 · USD · NASDAQ · Izjava

Datavault AI Inc

0,71 $

DVLT4,18 %

Crispr Therapeutics AG

52,61 $

CRSP1,68 %

New Era Energy & Digital Inc

5,49 $

NUAI26,79 %

Intellia Therapeutics Inc

12,83 $

NTLA2,64 %

Beam Therapeutics Inc

30,97 $

BEAM0,82 %

Sangamo Therapeutics Inc

0,37 $

SGMO8,82 %

Caribou Biosciences Inc

1,39 $

CRBU4,79 %

Vertex Pharmaceuticals Inc

442,08 $

VRTX0,16 %

Prime Medicine Inc

3,89 $

PRME2,26 %

Pacific Biosciences of California Inc

2,36 $

PACB6,79 %

Prejšnji trg. dan.

2,03 $

Dnevni razpon

1,92 $ - 2,06 $

Letni razpon

0,91 $ - 4,54 $

Tržna kapitalizacija

197,19 mio. USD

Povprečni obseg

1,84 mio.

Razm. P/E

-

Dividendna donosnost

-

Primarna borza

NASDAQ

Borzne novice

pred 8 minutami

Rigetti Computing (NASDAQ:RGTI) Stock Price Down 2.5% - Should You Sell?

On A Day that the S&P Falls Over 2%, Is This Tech Giant Finally a Buy?

pred 56 minutami

Chilwa Minerals Completes Final Tranche of A$8m Placement and Prepares for Nasdaq Dual Listing

pred 46 minutami

Stock futures are little changed after S&P 500 and Dow notch worst day since October: Live updates

S&P 500 has its worst day since October. Here's why stocks were down.

These stocks were the biggest losers on the S&P 500’s worst day in three months

Vizitka

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia

Datum ustanovitve

nov. 2013

Spletno mesto

editasmedicine.com

Zaposleni

246

Iskanje

Počisti iskanje

Zapiranje iskanja

Googlove aplikacije

Glavni meni